Show simple item record

Regenerating nodules–are they premalignant lesions?

dc.contributor.authorGumucio, Jorge J.en_US
dc.contributor.authorWright, Teresa L.en_US
dc.date.accessioned2006-04-28T16:54:18Z
dc.date.available2006-04-28T16:54:18Z
dc.date.issued1991-06en_US
dc.identifier.citationGumucio, Jorge J; Wright, Teresa L. (1991)."Regenerating nodules–are they premalignant lesions?." Hepatology 13(6): 1254-1255. <http://hdl.handle.net/2027.42/38360>en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/38360
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2050340&dopt=citationen_US
dc.description.abstractIn the period 1985–1988, 62 focal liver lesions in 58 cirrhotic patients were studied by ultrasonography; 12 of these focal lesions were documented to be regenerating lesions by echo-guided fine-needle biopsy. During an average follow-up period of 10.2 months (range 3–22 months), hepatocellular carcinoma was subsequently found in 10 of the cases of regenerating nodules, whereas the initial diagnosis of regenerating nodule was confirmed in the remaining two cases. Based upon this finding, it is suggested that every focal mass visualized by ultrasonography in a cirrhotic liver should either considered to be a neoplastic lesion or at least a preneoplastic lesion if the possibility of either a metastatic or benign lesion (eg hemangiomas, focal fatty liver change areas) can be excluded. Therefore either fine-needle aspiration or biopsy of all ultrasonographically revealed mass lesions within a cirrhotic liver is advised, such that early appropriate treatment for hepatocellular carcinoma can be instituted.en_US
dc.format.extent256085 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherW.B. Saundersen_US
dc.publisherWiley Periodiocals, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherHepatologyen_US
dc.titleRegenerating nodules–are they premalignant lesions?en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Gastroenterology (111D), VA Medical Center/University of Michigan, Ann Arbor, Michigan 48105en_US
dc.contributor.affiliationotherUniversity of California, San Francisco, Gastroenterology Unit, VA Medical Center, San Francisco, California 94121en_US
dc.identifier.pmid2050340en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/38360/1/1840130635_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/hep.1840130635en_US
dc.identifier.sourceHepatologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.